Blood vessels are essential for cancer growth and progression, as they supply the tumor with oxygen and nutrients. However, current therapies targeting the tumor vasculature, such as VEGF pathway inhibitors, have yielded limited or mixed clinical outcomes. My laboratory seeks to understand the basic principles that govern blood vessel growth and specification, with the ultimate goal of designing more effective therapies that target tumor vasculature.

I earned my PhD from the University of Cambridge and A*STAR and was subsequently a postdoctoral fellow at A*STAR. I then established my laboratory at Stanford, where I was initially a Siebel Investigator and Instructor and am presently an assistant professor. My laboratory has been supported by the Stanford Ludwig Center for Cancer Stem Cell Research and Medicine, Stanford Maternal & Child Health Research Institute, Stanford Diabetes Research Center, California Institute for Regenerative Medicine, Siebel Investigatorship, Additional Ventures and the Bladder Cancer Advocacy Network, among other sources. My mentorship has been recognized by the Stanford Faculty Women’s Forum Inspiring Early Academic Career Award and the Stanford-HBMC Recognizing Individuals for Support and Empowerment Award.